Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating ...

New legislation proposed by a bipartisan and bicameral group of Congressional legislators and supported by the North Carolina ...

Antibody Specificity Testing Market is expected to Reach to US $1.9 Bn by 2035, Driven by Rising Demand for Personalized ...

The legislature hopes to establish a domestic center of excellence for biopharmaceutical manufacturing.

Givaudan’s Zensera Launch: In June 2025, Givaudan introduced Zensera, a lemon balm extract clinically proven to enhance calmness and cognitive performance at a low dosage, expanding opportunities in ...

Explore the necessity, types, challenges, and potential of bioremediation in India for environmental restoration and public ...

BTIG announced today that its 5 th Annual Ophthalmology Day will take place on Monday, December 1, 2025. The virtual, one-day event will include thematic panel discussions and one-on-one meetings. The ...

The U.S. Department of Health and Human Services (HHS) has canceled almost $500 million in funding for mRNA vaccine projects, alleging worries about safety and efficacy. They are winding down nearly ...

Phylogenetic Tree Reconstruction Using the Fitch-Margoliash (FM) Algorithm - https://github.com/virtual-labs/exp-fm-tree-au/tree/main/, Master Branch, v1.0.0 ...

The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder, will ...

WASHINGTON, Jan 15 (Reuters) - The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security concerns ...